This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 21 
1 out of 1,327 
Years Active: 2017
Title: Innovations of Ying-Qian Liu
Introduction
Ying-Qian Liu is a notable inventor based in Province, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents.
Latest Patents
Ying-Qian Liu holds 1 patent related to novel 20-sulfonylamidine derivatives of camptothecin. This invention includes a method of synthesizing these derivatives and their use as an antitumor agent, specifically for treating nasopharyngeal, lung, breast, or prostate cancer.
Career Highlights
Throughout his career, Ying-Qian Liu has worked with prestigious institutions such as China Medical University Hospital and the University of North Carolina at Chapel Hill. His work has focused on advancing cancer treatment through innovative chemical compounds.
Collaborations
Ying-Qian Liu has collaborated with esteemed colleagues, including Kuo-Hsiung Lee and Keduo Qian, to further his research and development efforts.
Conclusion
Ying-Qian Liu's contributions to the field of antitumor agents highlight his innovative spirit and dedication to improving cancer treatment options. His work continues to inspire advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile